Uterine artery Doppler and biochemical markers (PAPP-A, PlGF, sFlt-1, P-selectin, NGAL) at 11+0 to 13+6weeks in the prediction of late (>34weeks) pre-eclampsia

Prenatal Diagnosis

Volumn 31, Issue 12, 2011, Pages 1141-1146

  Youssef, Aly ^a   Righetti, Francesca ^a   Morano, Danila ^b   Rizzo, Nicola ^a   Farina, Antonio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

Biochemical makers; First trimester screening; Logistic regression; Pre eclampsia; Uterine artery Doppler

Indexed keywords

BIOLOGICAL MARKER; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PADGEM PROTEIN; PLACENTAL GROWTH FACTOR; PREGNANCY ASSOCIATED PLASMA PROTEIN A; SOLUBLE FMS LIKE TYROSINE KINASE 1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; DOPPLER ECHOGRAPHY; FALSE POSITIVE RESULT; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; NEWBORN SCREENING; PLACENTA; PREECLAMPSIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; UTERINE ARTERY;

ACUTE-PHASE PROTEINS; ADULT; BIOLOGICAL MARKERS; FEMALE; FORECASTING; HUMANS; LIPOCALINS; MASS SCREENING; MEMBRANE PROTEINS; P-SELECTIN; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, THIRD; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PROSPECTIVE STUDIES; PROTO-ONCOGENE PROTEINS; ULTRASONOGRAPHY, DOPPLER, PULSED; UTERINE ARTERY; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

UTA;

EID: 82255183117     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2848     Document Type: Article

References (36)

1. Akolekar R, Syngelaki A, Sarquis R, Zvanca M, Nicolaides KH. 2011. Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks. Prenat Diagn 31: 66-74.
2. Akolekar R, Zaragoza E, Poon LC, Pepes S, Nicolaides KH. 2008. Maternal serum placental growth factor at 11+0 to 13+6weeks of gestation in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol 32: 732-739.
3. Audibert F, Boucoiran I, An N, et al. 2010. Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women. Am J Obstet Gynecol 203: 383. e1-e8.
4. Banzola I, Farina A, Concu M, et al. 2007. Performance of a panel of maternal serum markers in predicting preeclampsia at 11-15weeks' gestation. Prenat Diagn 27: 1005-1010.
5. Bonno M, Oxvig C, K Gm, et al. 1994. Localization of pregnancy-associated plasma protein-a and colocalization of pregnancy-associated plasma protein-a messenger ribonucleic acid and eosinophil granule major basic protein messenger ribonucleic acid in placenta. Lab Invest 71: 560-566.
6. Bujold E, Roberge S, Lacasse Y, et al. 2010. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 116: 402-414.
7. Cantwell R, Clutton-Brock T, Cooper G, et al. 2011. Saving Mothers' Lives: Reviewing maternal deaths to make motherhood safer: 2006-2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG 118(Suppl 1): 1-203.
8. Cnossen JS, Vollebregt KC, de Vrieze N, et al. 2008. Accuracy of mean arterial pressure and blood pressure measurements in predicting preeclampsia: systematic review and meta-analysis. BMJ 336: 1117-1120.
9. D'Anna R, Baviera G, Giordano D, et al. 2009. First trimester serum PAPP-A and NGAL in the prediction of late-onset pre-eclampsia. Prenat Diagn 29: 1066-1068.
10. De Paco C, Kametas N, Rencoret G, et al. 2008. Maternal cardiac output between 11 and 13weeks of gestation in the prediction of preeclampsia and small for gestational age. Obstet Gynecol 111: 292-300.
11. Farina A, Zucchini C, Sekizawa A, et al. 2010. Performance of messenger RNAs circulating in maternal blood in the prediction of preeclampsia at 10-14weeks. Am J Obstet Gynecol 203(575): e1-e7.
12. Giguère Y, Charland M, Bujold E, et al. 2011. Combining biochemical and ultrasonographic markers in predicting preeclampsia: a systematic review. Ann Biol Clin 69: 257-271.
13. Irwin JC, Suen LF, Martina NA, et al. 1999. Role of the IGF system in trophoblast invasion and pre-eclampsia. Hum Reprod 14(Suppl. 2): 90-96.
14. Jacobs M, Nassar N, Roberts CL, Hadfield R, Morris JM, Ashton AW. 2011. Levels of soluble fms-like tyrosine kinase one in first trimester and outcomes of pregnancy: a systematic review. Reprod Biol Endocrinol 9: 77.
15. Khalil A, Cowans NJ, Spencer K, et al. First-trimester markers for the prediction of preeclampsia in women with a-priori high risk. 2010. Ultrasound Obstet Gynecol 35: 671-679.
16. Lawrence JB, Oxvig C, Overgaard MT, et al. 1999. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci USA 96: 3149-3153.
17. Leslie K, Thilaganathan B, Papageorghiou A. 2011. Early prediction and prevention of pre-eclampsia. Best Pract Res Clin Obstet Gynaecol 25: 343-354.
18. Levine RJ, Maynard SE, Qian C, et al. 2004. Circulating angiogenic factors and the risk of preeclampsia.N Engl J Med 350: 672-683.
19. Liu Z, Miner JJ, Yago T, et al. 2010. Differential regulation of human and murine P-selectin expression and function in vivo. J Exp Med 207: 2975-2987.
20. Mishra J, Dent C, Tarabishi R, et al. 2005. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 365: 1231-1238.
21. Onwudiwe N, Yu CK, Poon LC, Spiliopoulos I, Nicolaides KH. 2008. Prediction of pre-eclampsia by a combination of maternal history, uterine artery Doppler and mean arterial pressure. Ultrasound Obstet Gynecol 32: 877-883.
22. Phillips JK, Janowiak M, Badger GJ, Bernstein IM. 2010. Evidence for distinct preterm and term phenotypes of preeclampsia. J Matern Fetal Neonatal Med 23: 622-626.
23. Plasencia W, Maiz N, Bonino S, Kaihura C, Nicolaides KH. 2007. Uterine artery Doppler at 11+0 to 13+6weeks in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol 30: 742-749.
24. Poon LC, Akolekar R, Lachmann R, Beta J, Nicolaides KH. 2010. Hypertensive disorders in pregnancy: screening by biophysical and biochemical markers at 11-13 weeks. Ultrasound Obstet Gynecol 35: 662-670.
25. Poon LC, Maiz N, Valencia C, Plasencia W, Nicolaides KH. 2009a. First trimester maternal serum pregnancy-associated plasma protein-A and preeclampsia. Ultrasound Obstet Gynecol 33: 23-33.
26. Poon LC, Staboulidou I, Maiz N, Plasencia W, Nicolaides KH. 2009b. Hypertensive disorders in pregnancy: screening by uterine artery Doppler at 11-13 weeks. Ultrasound Obstet Gynecol 34: 142-148.
27. Poon LCY, Karagiannis G, Leal A, Romero XC, Nicolaides KH. 2009c. Hypertensive disorders in pregnancy: screening by uterine artery Doppler imaging and blood pressure at 11-13 weeks. Ultrasound Obstet Gynecol 34: 497-502.
28. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. 2000. Am J Obstet Gynecol 183: S1-S22.
29. Riskin-Mashiah S, Belfort MA, Saade GR, Herd JA. 2002. Transcranial Doppler measurement of cerebral velocity indices as a predictor of preeclampsia. Am J Obstet Gynecol 187: 1667-1672.
30. Sibai BM, Koch MA, Freire S, et al. 2008. Serum inhibin A and angiogenic factor levels in pregnancies with previous preeclampsia and/or chronic hypertension: are they useful markers for prediction of subsequent preeclampsia? Am J Obstet Gynecol 199: 268.e1-268.e9.
31. Spencer K, Cowans NJ, Chefetz I, et al. 2007. First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of preeclampsia. Ultrasound Obstet Gynecol 29: 128-134.
32. Steegers EAP, Von Dadelszen P, Duveko JJ, Pijnenborg R. 2010. Pre-eclampsia. Lancet 376: 631-644.
33. Tuffnell DJ, Shennan AH, Waugh JJS, Walker JJ. 2006. The management of severe pre-eclampsia/eclampsia, guideline number 10(A). London: Royal College of Obstetricians and Gynaecologists.
34. Valensise H, Vasapollo B, Gagliardi G, Novelli GP. 2008. Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease. Hypertension 52: 873-880.
35. Yu CK, Smith GC, Papageorghiou AT, et al. 2005. Fetal medicine foundation second trimester screening Group. An integrated model for the prediction of preeclampsia using maternal factors and uterine artery Doppler velocimetry in unselected low-risk women. Am J Obstet Gynecol 193: 429-436.
36. Yu J, Shixia CZ, Wu Y, Duan T. 2011. Inhibin A, activin A, placental growth factor and uterine artery Doppler pulsatility index in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol 37: 528-533.